An Open-Label Phase ½ Study of INCB039110 in Combination With Ibrutinib in Subjects with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Type of Cancer
Lymphoma

Sponsor
Incyte

Protocol Number
INCB 39110-206

To Learn More Call
(201)-510-0950